BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 21670498)

  • 41. Antisense oligonucleotide induction of progerin in human myogenic cells.
    Luo YB; Mitrpant C; Adams AM; Johnsen RD; Fletcher S; Mastaglia FL; Wilton SD
    PLoS One; 2014; 9(6):e98306. PubMed ID: 24892300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis.
    Luo YB; Mitrpant C; Johnsen R; Fabian V; Needham M; Fletcher S; Wilton SD; Mastaglia FL
    Int J Clin Exp Pathol; 2013; 6(9):1723-33. PubMed ID: 24040437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
    Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients.
    Viteri G; Chung YW; Stadtman ER
    Mech Ageing Dev; 2010 Jan; 131(1):2-8. PubMed ID: 19958786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping of lamin A- and progerin-interacting genome regions.
    Kubben N; Adriaens M; Meuleman W; Voncken JW; van Steensel B; Misteli T
    Chromosoma; 2012 Oct; 121(5):447-64. PubMed ID: 22610065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of novel RNA isoforms of LMNA.
    DeBoy E; Puttaraju M; Jailwala P; Kasoji M; Cam M; Misteli T
    Nucleus; 2017 Sep; 8(5):573-582. PubMed ID: 28857661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells.
    Bidault G; Garcia M; Capeau J; Morichon R; Vigouroux C; Béréziat V
    Cells; 2020 May; 9(5):. PubMed ID: 32408587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
    Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
    Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
    Eisch V; Lu X; Gabriel D; Djabali K
    Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lamin A and telomere maintenance in aging: Two to Tango.
    Sengupta D; Sengupta K
    Mutat Res; 2022; 825():111788. PubMed ID: 35687934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide Y Enhances Progerin Clearance and Ameliorates the Senescent Phenotype of Human Hutchinson-Gilford Progeria Syndrome Cells.
    Aveleira CA; Ferreira-Marques M; Cortes L; Valero J; Pereira D; Pereira de Almeida L; Cavadas C
    J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1073-1078. PubMed ID: 32012215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of differential protein interactors of lamin A and progerin.
    Kubben N; Voncken JW; Demmers J; Calis C; van Almen G; Pinto Y; Misteli T
    Nucleus; 2010; 1(6):513-25. PubMed ID: 21327095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smurf2 regulates stability and the autophagic-lysosomal turnover of lamin A and its disease-associated form progerin.
    Borroni AP; Emanuelli A; Shah PA; Ilić N; Apel-Sarid L; Paolini B; Manikoth Ayyathan D; Koganti P; Levy-Cohen G; Blank M
    Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29405587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accumulation of distinct prelamin A variants in human diploid fibroblasts differentially affects cell homeostasis.
    Candelario J; Borrego S; Reddy S; Comai L
    Exp Cell Res; 2011 Feb; 317(3):319-29. PubMed ID: 20974128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins.
    Wang Y; Ostlund C; Choi JC; Swayne TC; Gundersen GG; Worman HJ
    Nucleus; 2012; 3(5):452-62. PubMed ID: 22895092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress.
    Trigueros-Motos L; Gonzalez JM; Rivera J; Andres V
    Front Biosci (Schol Ed); 2011 Jun; 3(4):1285-97. PubMed ID: 21622271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome.
    Davies BS; Yang SH; Farber E; Lee R; Buck SB; Andres DA; Spielmann HP; Agnew BJ; Tamanoi F; Fong LG; Young SG
    J Lipid Res; 2009 Jan; 50(1):126-34. PubMed ID: 18757838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of progerin-interactive partner proteins with lamina proteins: Mel18 is associated with emerin in HGPS.
    Ju WN; Brown WT; Zhong N
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 41(4):397-401. PubMed ID: 19727227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging.
    Chang W; Wang Y; Luxton GWG; Östlund C; Worman HJ; Gundersen GG
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3578-3583. PubMed ID: 30808750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway.
    Kinoshita D; Nagasawa A; Shimizu I; Ito TK; Yoshida Y; Tsuchida M; Iwama A; Hayano T; Minamino T
    Oncotarget; 2017 May; 8(21):34045-34056. PubMed ID: 28423660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.